Osteoporosis diagnosis and screening

Clinical Cornerstone - Tập 8 - Trang 9-18 - 2006
Andrea Singer1
1Medicine and Obstetrics and Gynecology Georgetown University Hospital Washington, DC, USA

Tài liệu tham khảo

National Osteoporosis Foundation, 2002 National Osteoporosis Foundation, 2006 Black, 2000, Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial, J Clin Endocrinol Metab, 85, 4118, 10.1210/jc.85.11.4118 Black, 1996, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group, Lancet, 348, 1535, 10.1016/S0140-6736(96)07088-2 Orwoll, 2000, Alendronate for the treatment of osteoporosis in men, N Engl J Med, 343, 604, 10.1056/NEJM200008313430902 Ringe, 2001, Alendronate treatment of established primary osteoporosis in men: Results of a 2-year prospective study, J Clin Endocrinol Metab, 86, 5252, 10.1210/jc.86.11.5252 Sorensen, 2003, Long-term efficacy of risedronate: A 5-year placebo-controlled clinical experience, Bone, 32, 120, 10.1016/S8756-3282(02)00946-8 Reginster, 2000, Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group, Osteoporos Int, 11, 83, 10.1007/s001980050010 Ringe, 2006, Efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 1-year study, Rheumatol Int, 26, 427, 10.1007/s00296-005-0004-4 World Health Organization, 2006, Prevention and management of osteoporosis van der Klift, 2005, Assessment of fracture risk: Who should be treated for osteoporosis?, Best Pract Res Clin Rheumatol, 19, 937, 10.1016/j.berh.2005.06.001 National Osteoporosis Foundation, 2003 Lewiecki, 2004, Position statement. Official positions of the International Society for Clinical Densitomerry, J Clin Endocrinol Metab, 89, 3651, 10.1210/jc.2004-0124 Lane, 2006, Epidemiology, etiology, and diagnosis of osteoporosis, Am J Obstet Gynecol, 194, S3, 10.1016/j.ajog.2005.08.047 Siris, 2004, Bone mineral density thresholds for pharmacological intervention to prevent fractures, Arch Intern Med, 164, 1108, 10.1001/archinte.164.10.1108 Gudmundsdottir, 2005, Age-related decline in bone mass measured by dual-energy X-ray absorptiometry and quantitative ultrasound in a population-based sample of both sexes: Identification of useful ultrasound thresholds for osteoporosis screening, J Clin Densitom, 8, 80, 10.1385/JCD:8:1:080 Picard, 2004, Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement, J Clin Densitom, 7, 111, 10.1385/JCD:7:1:111 Moayyeri, 2006, Preferred skeletal site for osteoporosis screening in high-risk populations, Public Health, 120, 863, 10.1016/j.puhe.2006.05.013 ACOG Committee Opinion, 2002, Bone density screening for osteoporosis, Int J Gynaecol Obstet, 77, 299, 10.1016/S0020-7292(02)90064-0 Edwards, 2004, Osteoporosis screening of postmenopausal women in the primary care setting: A case-based approach, Gender Med, 1, 70, 10.1016/S1550-8579(04)80013-5 Nishihara, 2005, Evaluation of osteoporosis in X-ray CT examination: A preliminary study for an automatic recognition algorithm for the central part of a vertebral body using abdominal X-ray CT images, Comput Med Imaging Graph, 29, 259, 10.1016/j.compmedimag.2004.12.001 Briot, 2005, What is the role of DXA, QUS, and bone markers in fracture prediction, treatment allocation and monitoring?, Best Pract Res Clin Rheumatol, 19, 951, 10.1016/j.berh.2005.06.004 Nayak, 2006, Meta-analysis: Accuracy of quantitative ultrasound for identifying patients with osteoporosis, Ann Intern Med, 144, 832, 10.7326/0003-4819-144-11-200606060-00009 2004, Position statement: Executive summary, J Clin Densitom, 7, 7, 10.1385/JCD:7:1:7 Cadarette, 2000, Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry, CMAJ, 162, 1289 Weinstein, 2000, Identification of at-risk women for osteoporosis screening, Am J Obstet Gynecol, 183, 547, 10.1067/mob.2000.106594 Cadarette, 1999, Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry, Osteoporos Int, 10, 85, 10.1007/s001980050199 Cadarette, 2001, Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry, JAMA, 286, 57, 10.1001/jama.286.1.57 Richy, 2004, Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium, QJM, 97, 39, 10.1093/qjmed/hch002